USFDA completes inspection of Wockhardt’s manufacturing unit in Himachal Pradesh

24 Jul 2015 Evaluate

Wockhardt’s inspection of its manufacturing unit located at 57, Kunjhal Barotiwala, Nalagarh, District Solan, Himachal Pradesh by U S Food and Drug Administration (USFDA) has since been completed. Further, no Form 483 has been issued by USFDA in this regard.

Wockhardt is one of the few companies with end to end integrated capabilities for its products, starting with the manufacture of the oral and sterile API’s, the dose forms and marketing through wholly owned subsidiary in the US, enabling the company to capture maximum value.


Wockhardt Share Price

1430.75 -15.15 (-1.05%)
01-Jan-2026 09:43 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1712.00
Dr. Reddys Lab 1253.30
Cipla 1501.30
Zydus Lifesciences 909.00
Lupin 2092.90
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×